TuHURA BIOSCIENCES, INC./NV Amortization of Debt Discount (Premium)
TuHURA BIOSCIENCES, INC./NV (HURA) reported Amortization of Debt Discount (Premium) of $481.42 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-03-31
- TuHURA BIOSCIENCES, INC./NV amortization of debt discount (premium) for the quarter ending 2024-12-31 was $171.41K.
- TuHURA BIOSCIENCES, INC./NV amortization of debt discount (premium) for the quarter ending 2024-09-30 was $668.84K.
- TuHURA BIOSCIENCES, INC./NV amortization of debt discount (premium) for the quarter ending 2024-06-30 was $420.79K.
- TuHURA BIOSCIENCES, INC./NV amortization of debt discount (premium) for the quarter ending 2024-03-31 was $17.38K.
- TuHURA BIOSCIENCES, INC./NV amortization of debt discount (premium) for fiscal 2025 was $481.42K, a 62.34% decline from fiscal 2024.
- TuHURA BIOSCIENCES, INC./NV amortization of debt discount (premium) for fiscal 2024 was $1.28M, a 24849.73% increase from fiscal 2023.
- TuHURA BIOSCIENCES, INC./NV amortization of debt discount (premium) for fiscal 2023 was $5.12K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $481.42K 10-K · filed 2026-03-31 | |||
| 2024-12-31 | $171.41K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $840.25K derived: sum of 2 quarters · filed 2026-03-31 | $1.26M derived: sum of 3 quarters · filed 2026-03-31 | $1.28M 10-K · filed 2026-03-31 |
| 2024-09-30 | $668.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.09M derived: sum of 2 quarters · filed 2025-11-14 | $1.11M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $420.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $438.17K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $17.38K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $5.12K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |